Clinical Trials Directory

Trials / Unknown

UnknownNCT05852080

Multilevel System Intervention Based on Information Platform to Reduce Ischemic Stroke Recurrence Rate

Multilevel System Intervention Based on Information Platform to Reduce Stroke Recurrence Rate in Acute Ischemic Stroke Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, multicenter and cluster randomised controlled trial will be conducted, using hospital as randomisation unit. Hospitals in Zhejiang Province, China, will be randomised into two arms (1:1): an intervention arm and a control arm. Hospitals in the intervention arm will receive a multilevel system intervention based on information platform, whereas hospitals in the control arm will receive no intervention. The randomisation will be conducted after baseline data collection. The following baseline data will be used for randomisation match: hospital classification, beds in stroke centre, and the number of acute ischemic stroke (AIS) patients within 7 days of stroke onset. Hospitals with \<250 AIS cases per year will be excluded from the study. The primary outcome will be difference between intervention arm and control arm in the one-year stroke recurrence rate on the follow-up stage (post-intervention).

Conditions

Interventions

TypeNameDescription
BEHAVIORALmultilevel system intervention based on information platform1. Standardized templates of medical record 2. Continuous medical quality control and feedback system: the hospital included in the study upload the medical records of all AIS patients by medical records scanning system. Quality control platform of Cerebral apoplexy in Zhejiang province extracts and analyze the data through the computer and calculates the percentage of stroke of undetermined cause. 3. Team collaboration based on video conferencing: hospitals will receive corresponding suggestions for their improvement from experts online. 4. Enhanced feedback incentives

Timeline

Start date
2023-05-01
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2023-05-10
Last updated
2023-05-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05852080. Inclusion in this directory is not an endorsement.